Body Weight Changes with β-Blocker Use: Results from GEMINI

2007/07/01 by Franz H. Messerli, David S.H. Bell, Vivian Fonseca +11 · 23 citations
Medicine · #Diabetes Treatment and Management #Blood Pressure and Hypertension Studies #Pharmacology and Obesity Treatment

paper · doi:10.1016/j.amjmed.2006.10.017

Cited by

• Ten putative contributors to the obesity epidemic. [europepmc]
• Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat. [europepmc]
• Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease. [europepmc]
• Beyond fast food and slow motion: weighty contributors to the obesity epidemic. [europepmc]
• β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol. [europepmc]
• Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery. [europepmc]
• Avoiding weight gain in cardiometabolic disease: a systematic review. [europepmc]
• Obesity in Women: Insights for the Clinician. [europepmc]
• Insights on β-blockers for the treatment of hypertension: A survey of health care practitioners. [europepmc]
• A comprehensive diagnostic approach to detect underlying causes of obesity in adults. [europepmc]
• Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes. [europepmc]
• Maternal Gestational Weight Gain in Relation to Antidepressant Continuation in Pregnancy. [europepmc]
• Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation. [europepmc]
• A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management. [europepmc]
• Long-term exposure to polypharmacy impairs cognitive functions in young adult female mice. [europepmc]
• Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetes. [europepmc]
• Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension. [europepmc]
• Case report of PLXNA4 variant associated with hyper-response to phentermine/topiramate pharmacotherapy: Potential genetic basis for superior weight loss response? [europepmc]
• Effects of Pharmaceutical Substances with Obesogenic Activity on Male Reproductive Health. [europepmc]
• Treatment options for heart failure in individuals with overweight or obesity: a review. [europepmc]
• Emulation of a Target Trial of Antihypertensive Medications on Weight Change. [europepmc]
• 3D bioprinted human-scale intestine models for physiological and microbial insights through fluid-driven heterogeneity. [europepmc]
• A Modern Perspective on β‐Blocker Use in Hypertension: Clinical Trials and Their Influence on Clinical Practice [europepmc]